Signal2026-03-24
ClinicalTrials.gov

[PHASE1] The ENERGY Study: Evaluation of Safety and Tolerability of INZ-701 in Infants With ENPP1 Deficiency or ABCC6 Deficiency

Part of

Precision Diagnostics And Screening Innovations